Leukemia Research
Volume 29, Issue 6 , Pages 679-683, June 2005

Rituximab therapy of lymphoma is enhanced by orally administered (1→3),(1→4)-d-β-glucan

  • Shakeel Modak

      Affiliations

    • Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 212 6397623; fax: +1 212 7442245.
    • ,
  • Guenther Koehne

      Affiliations

    • Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY, USA
    • ,
  • Andrew Vickers

      Affiliations

    • Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY, USA
    • Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY, USA
    • ,
  • Richard J. O’Reilly

      Affiliations

    • Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY, USA
    • ,
  • Nai-Kong V. Cheung

      Affiliations

    • Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY, USA

Received 20 August 2004; accepted 27 October 2004.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0145-2126(04)00380-7

doi:10.1016/j.leukres.2004.10.008

Leukemia Research
Volume 29, Issue 6 , Pages 679-683, June 2005

Article Tools

* Image Usage & Resolution